Filing metadata

Accession number
0001104659-26-010478
Form type
Form 4
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Feb 04, 2026
Reporting period
Feb 02, 2026
Description
Insider transaction

Explore SEC Filings Hub